CDSCO Identifies 167 Substandard and Seven Spurious Drug Samples in December 2025

In December 2025, India's Central Drugs Laboratories and State Drugs Testing Laboratories identified 167 drug samples as not of standard quality (NSQ) during routine surveillance. Additionally, seven spurious drug samples were detected, produced by unauthorized manufacturers using brand names of other companies. These findings, covering various common medicines, are published monthly on the CDSCO portal. Investigations are ongoing, and regulatory actions will follow to ensure substandard and spurious drugs are removed from the market, reflecting active quality control efforts.